A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

NCT06598046 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Utidelone and capecitabine

Sponsor

Henan Cancer Hospital